Clinical Trial: A Study of CDX-585 in Patients With Advanced Malignancies
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Non-small Cell Lung Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies
Brief Summary:
This is an open-label, non-randomized, multicenter, dose-escalation and expansion study in patients with selected solid tumors.
Read more